In a mouse model of T2DM, the compound 5-(4-methylpiperazin-1-yl)-2-nitroaniline upregulated GLUT1 expression to improve blood glucose levels by inhibiting SIRT6 deacetylase activity [115]. This evidence concerns the gene SLC2A1 and type 2 diabetes mellitus.